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Abstract
Background: Health state utility values allow for comparison of treatments across different diseases. Utility values
for fertility-impaired health states are currently unavailable. Such values are necessary in order to determine the
relative costs-effectiveness of fertility treatments.
Methods: This study aimed to determine utility weights for infertile and subfertile health states. In addition, it explored
the Dutch general population’s opinions regarding the inclusion of infertility treatments in the Dutch health insurers’
basic benefit package. An online questionnaire was designed to determine the health-related quality of life values of
six fertility-impaired health states. The study population consisted of a representative sample of the Dutch adult
population. Respondents were asked to evaluate the health states through direct health valuation methods, i.e. the
Visual Analogue Scale (VAS) and the Time Trade-Off (TTO) method. In addition, respondents were asked about their
opinions regarding reimbursement of fertility-related treatments.
Results: The respondents’ (n = 767) VAS scores ranged from 0.640 to 0.796. TTO utility values ranged from 0.792
to 0.868. Primary infertility and subfertility was valued lower than secondary infertility and subfertility. In total, 92%
of the respondents stated that fertility treatments should be fully or partially reimbursed by the health insurance
basic benefit package.
Conclusions: Having fertility problems results in substantial disutilities according to the viewpoint of the Dutch
general population. The results make it possible to compare the value for money of infertility treatment to that of
treatments in other disease areas. There is strong support among the general population for reimbursing fertility
treatments through the Dutch basic benefit package.
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Plain English summary
World-wide, about 15 % of the people experience diffi-
culties with getting pregnant. Several treatments are
available to help people who have fertility problems.
These treatments are usually too expensive for people to
pay for themselves. In the Netherlands, these treatments
are therefore often paid for by the health insurers.
Nevertheless, it is regularly questioned whether such
treatments should be paid from national health care
budgets, since people may not directly consider
infertility to be a condition for which society should pay
the treatment.
This study was conducted to determine whether the
general population thinks fertility treatments should be
paid for by general means. It was also investigated how
much people thought their life would be impacted if
they wanted to have children, but were not able to.
Several persons (767) representing the Dutch adult
general population were asked about their views on
having trouble conceiving. They were asked to partici-
pate via an online questionnaire.
The results of this study showed that most persons in
the Netherlands are in favour of paying for fertility treat-
ments through the mandatory national Dutch basic
health insurance package. About 10% of the people
thought this should not be the case. In general, the
expected impact of having fertility problems was quite
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high. To illustrate, this impact was comparable to having
migraine attacks twice a week.
Background
Approximately 15% of reproductive-aged couples experi-
ence infertility worldwide [19]. In this paper, infertility is
defined as permanently being unable to have children
and subfertility as having trouble conceiving and not
knowing whether potential fertility treatments will be
successful. Mascarenhas et al. estimated that 48.5 million
couples worldwide are unable to fulfill their desire for a
child (which was defined as not being able to conceive
in the past five years). Of these, 19.2 million couples fail
to have a first child and 29.3 million fail to have an
additional child [15]. About half of the couples in indus-
trialized countries facing infertility seek medical help
[18]. Fertility problems affect individuals in high income
countries, as well as individuals in middle- and low-in-
come countries [15].
Despite the high number of people having fertility
problems, it is regularly questioned whether this justifies
a claim on national health care budgets. The difficulty is
that, although fertility is seen as a normal bodily func-
tion, policy makers may not directly consider infertility
to be a disease or condition to which national health
care spending should be allocated. In the Netherlands,
for instance, there is an ongoing debate addresses
whether fertility treatments should be (fully) reimbursed
(e.g. [17]). Currently, in the Netherlands, couples get a
maximum of three in vitro fertilization (IVF) or intracy-
toplasmic sperm injection (ICSI) attempts reimbursed
through the basic benefit package of the mandatory
health insurance [22]. Similarly, in many other countries
there is limited access to fertility care through health
insurance schemes or National Health Service systems.
An important reason why policy makers limit access
to fertility treatment is the pressure on health care bud-
gets. Because budgets are limited, decisions between re-
imbursement of various treatments must be made.
Health economic evaluations in the form of cost-effect-
iveness studies play an increasing role in such health
care decision making. Cost-effectiveness studies inform
decision makers about the relative value-for-money that
treatments offer. Such studies influence whether treat-
ments are included in the health insurance benefit pack-
ages or the national health services systems; i.e. whether
patients must pay for treatment themselves or whether
the costs of treatment will be reimbursed. This also ap-
plies to reimbursement decisions concerning medical
help for fertility problems.
Outcomes of cost-effectiveness analysis are preferably
expressed in costs per quality -adjusted life year (QALY).
QALYs allow comparison of treatments and outcomes
across diseases. Decision makers can for instance,
compare the cost-effectiveness of fertility treatment with
the cost-effectiveness of treatments for rheumatoid arth-
ritis. To be able to compute QALY outcomes, prefer-
ence-based health-related quality of life values (also
called utilities) need to be available so that costs per
QALY can be calculated. A recent review [12] showed
that utilities for fertility-impaired health states are cur-
rently lacking. Consequently, health economic studies
on fertility treatment often examine the costs of fertility
treatment per live birth, rather than the costs per QALY
gained. The difficulty for policy makers is that costs per
live birth cannot be compared with cost-effectiveness
outcomes of other medical interventions treating other
diseases.
Methods
Aims
The objective of this study was to determine utility
weights for infertile and subfertile health states by direct
utility measurement in the Dutch adult population. In
addition, the study explored the general populations’
views on reimbursement of fertility treatment.
Respondents
Data were gathered in January and February 2018. A
sample of the general Dutch population was obtained
through an online market research company (Survey
Sampling International). The sample was representative
for the Dutch population (> 18 years) in terms of age
and sex.
Respondents were excluded from further analysis if
they spent an unrealistically short time used to answer
the questions (defined as <one-third of the median com-
pletion time), if they answered a validation question and
a subsequent validation question incorrectly, or if they
showed other clear signs of not having answered the
questions seriously, e.g. making strange remarks in open
answer field.
Respondents participated anonymously and with in-
formed consent, and all respondents agreed that their
answers would be used for scientific publication. After
finalization of the online questionnaire, they were
rewarded with a small amount of money to be donated
to a charity of their choice or the chance to win a
prize for themselves.
Sample size calculation
The study was powered based on the desired amount of
uncertainty around the estimates. Given the utility scale
of 0 to 1 (where 1 is considered equal to full health and
0 is considered equal to dead) a 95%-confidence interval
width of 0.06 was considered acceptable. Under a
normal distribution this corresponds with a standard
error of 0.0153. The standard deviation was assumed to
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be 0.39, which is the highest standard deviation of the
health state valuations in two comparable studies [11,
14].
These considerations led to a required sample size of
at least 650 respondents. Based on previous experience
with studies using a similar online sample and the time
trade-off technique, it was expected that 95% of the
responses could be used in the analyses (e.g. [1, 13]). For
extra certainty a total of 750 respondents were recruited.
Questionnaire
The questionnaire consisted of three sections: i) a back-
ground section, ii) a health state valuations section and
iii) a reimbursement opinions section. The questionnaire
was developed with help of a gynecologist specialized in
subfertility. This specialist provided input for al fertility-
related questions and helped to design realistic health
state descriptions.
Health state descriptions
Six fertility-related health states were described for
which utility values were elicited. Additionally, one
health state without fertility problems was described. Pa-
tients being in the fertility-impaired health states are ei-
ther 1) infertile (permanently unable to have children) or
2) subfertile (having trouble conceiving and uncertain
whether a fertility treatment will be successful. Further-
more, they either already have one or three children
(secondary subfertility/infertility) or they do not (pri-
mary subfertility/infertility). All seven health states relate
to a person who is 38 years old with an active
child-wish.
Health states definitions consisted of a general health
description, based on the EuroQol 5 Dimensions, 5 level
(EQ-5D-5 L) descriptive system, and a fertility-related
part. An overview of all seven health states is presented
in Table 1 and an example of a health state description
is provided in Fig. 1.
Health state valuations
In economic evaluations of healthcare, health gains are
expressed as QALYs. QALYs are the product of time and
quality of life (expressed as utility). The latter is
expressed on a scale with value 1 for perfect health and
0 for death.
In this study, two direct health state valuation methods
were applied to elicit the utility of the seven health
states; the Time Trade-Off (TTO) method and the Visual
Analogue Scale (VAS). Both methods are widely applied
and involve some biases (see for instance [4, 7]). In gen-
eral, economists prefer choice based methods such as
the TTO over a VAS [10].
TTO valuations
Respondents in the TTO valuation method were asked
to trade-off better health against a longer life. In this
case, they chose between spending the rest of their nor-
mal remaining life expectancy of 45 years in a state with
fertility problems, or living in full health for a shorter
amount of time (x years). If they were indifferent be-
tween the two options, this would mean that x years
with perfect quality of life were equally valuable to them
as 45 years in the other health state.
Mathematically, this can be expressed as follows, for
health states that are considered better than death:
Table 1 health states
General
health
state
Infertile
1
Infertile
2
Infertile
3
Subfertile 1 Subfertile 2 Subfertile 3
Fertility
Desire to have (more) children NS Yes Yes Yes Yes Yes Yes
Current number of children NS 0 1 3 0 1 0
Current treatment NS No No No IVF IVF IVF
General health
Mobility No problems No problems No problems No problems No problems No problems No problems
Self-care No problems No problems No problems No problems No problems No problems No problems
Daily activities Slight problems No problems No problems No problems Slight problems Slight problems No problems
Pain or discomfort Slight problems No problems No problems No problems Slight problems Slight problems No problems
Anxiety or depression Slight problems No problems No problems No problems Slight problems Slight problems No problems
Valuation method applied
VAS + + + + + + +
TTO + + + + – – –
IVF in vitro fertilization, NS is not specified, TTO time trade-off, VAS visual analogue scale
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1 x ¼ U 45; or U ¼ x=45;
where U denotes the quality of life in a specific health
state.
The indifference point x was determined through an
iterative process in which x was varied until the respon-
dents were indifferent. An example of the TTO valuation
question is provided in Fig. 2.
The iterative process was applied as follows. In the
example, respondents were first asked whether they pre-
ferred 45 years in full health (without fertility problems)
or 45 years in health state X (being infertile). If the re-
spondent chose 45 years in full health, the years in full
health were cut in half. Respondents were then asked if
they preferred 23 years in full health or 45 years in health
state X. If they chose 45 years in health state X, the years
Fig. 1 Example infertile health state description (infertile 2)
Fig. 2 TTO Example
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of full health were changed to the mid-point of 23 and
45 (= 34). If in the next question they chose 45 years in
health state X, years in full health were changed to the
mid-point between 34 and 45 (= ~ 40). This process was
repeated until either option C was chosen (i.e. point of
indifference is reached) or when the point was reached
that respondents were offered a choice between 44 years
in full-health and 45 years in health state X. In the latter
case the indifference point was assumed to be at 44.5
years in full-health (i.e. 6 months of living were assumed
to be traded-off ). If respondents chose option C at a
certain moment, then the offer of full-health presented
at that moment is the indifference point. For instance, if
a respondent in Fig. 2 chose option C, the indifference
point was 23 years (i.e. 22 years were traded-off ). If re-
spondents in every iteration chose to prefer the lower
number of years in full-health (which was halved every
question), the iteration process stopped when the years
of full-health offered reached 1. Respondents were then
presented with a slider between 0 and 1 to indicate how
much time in full health between 0 and 1 year they felt
was equal to 45 years in the impaired health state. If, for
instance, they indicated 0.5 years, this meant that they
had traded-off 44.5 years. The utility values of the
presented health states were calculated by dividing the
number of years traded-off by 45 (the normal remaining
life span).
Since a TTO exercise is a relatively complex task, re-
spondents were first asked a validation question. In the
validation question a general health state (see Table 1)
was presented. Respondents were asked whether they
preferred 45 years in the general health state 1 (with
health problems), 45 years in full-health or whether they
were indifferent. If respondents stated that they pre-
ferred 45 years in health state 1 or that they were indif-
ferent, they were subsequently asked whether they were
sure in the validation question. If they answered this
validation question confirmative, the respondents’ an-
swers were excluded from further analysis.
The question was also used to check the average
valuation of this health state by the sample against the
valuation of the health state in the Dutch EQ-5D-5 L
tariff, which is 0.778 [20].
Note that the most commonly applied time horizon in
TTO questions is ten years [3]. However, as seen in Fig.
2, in this study remaining life expectancy was used in-
stead. The principal reason for this is that if life ends
after ten years, a potential child would still be young.
This perspective might make it seem less desirable to
have children at all. The life span of 83 years applied in
this study was based on the life expectancy for a
38-year-old person in the Netherlands [5].
TTO could not be applied for the subfertile health
states, since the method requires that the imperfect
health state is clearly defined and described in sufficient
detail. This was problematic, since the uncertainty about
being able to conceive in the subfertile health states may
be an important aspect influencing quality of life (i.e. the
utility values). It would therefore be inconsistent to tell
respondents whether infertility treatment would be
successful. Moreover, it would not be realistic to remain
uncertain of the IVF outcome over the entire remaining
life span of 45 years of a 38-year-old. For this reason,
TTO was only applied for the infertility health states
and the general health description.
Visual analogue scale valuations
The Visual Analogue Scale (VAS) is a straightforward
direct valuation method in which participants rate their
own health or a described health state on a scale from 0
to 100, see for example Fig.3. This method can also be
used for health states that involve uncertainty. On the
VAS rating scale ‘0’ represents the worst imaginable
health state and ‘100’ the best imaginable health state.
Respondents were first asked to rate their own health,
next they were asked to rate an impaired health state
not specifically entailing fertility problems (health state 1
in Table 1) and, subsequently the infertile and subfertile
health states were presented. Respondents were pre-
sented with a slider they could move between a value be-
tween 0 and 100. At the start of each health state
valuation task the slider was placed in the middle (at 50).
The respondent could only move to the next question
after having moved the slider. VAS scores were divided by
100 to make them more comparable with TTO scores.
Reimbursement opinions
The final section of the questionnaire consisted of
questions about the respondents’ opinions regarding reim-
bursement of fertility-related treatments by the Dutch
basic benefit package (mandatory health insurance pack-
age for the total population). Respondents were asked
whether they thought fertility-related treatments (more
specifically, IVF treatment) should be part of the Dutch
basic benefit package (fully, not at all, partly) If they
answered that fertility treatments should be partly reim-
bursed by the basic benefit package, they were asked how
many IVF attempts they thought should be reimbursed.
Analysis
The average TTO and VAS scores were calculated per
health state for the entire sample as well as for
subgroups of respondents (defined by gender, religion,
age, education, experience with fertility problems, and
wishing to have (more) children).
An extra step was taken to make the VAS estimates
for the subfertility health states comparable to the esti-
mates for the other health states that were elicited by
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TTO. Since TTO values are usually structurally higher
than VAS values, these VAS values were increased by the
average difference between the VAS and the TTO values
of the health states for which both were available.
Discounting
Respondents tend to value years further in the future
lower than more immediate ones, which could lead them
to give up future life years in exchange for utility gains
relatively easily. This would result in biased utility
estimates, since all years are equally valuable in the
QALY concept [2]. To correct this bias, the indifference
points from the TTO as well as the normal life expect-
ancy were discounted by the 1.5% per year rate that is
prescribed for future health benefits by the Dutch health
economic guidelines [21].
Results
Study population
At the interim analysis (half way through the process of
the data collection) it turned out that approximately
30% of the respondents did not give a correct answer to
the validation question. Therefore, the data collection
was prolonged aiming to collect a total of 950 completed
questionnaires instead of the originally planned 750.
Finally, 994 respondents completed the questionnaire.
Of those respondents, 599 answered the previously
described validation question correctly (i.e. stating that
they would rather live 45 years in full health than 45
years in an impaired health state). An additional 77 re-
spondents answered the validation question correctly
after asking them if they were sure about their answer.
None of the respondents correctly answering the valid-
ation question the first or second time were considered
speeders. Consequently, the answers of 676 respondents
were included in the analyses. The characteristics of these
respondents are summarized in Table 2. A majority of the
sample have children, and one-third would like to have
(had) (more) children. Twelve percent of the respondents
have had experience with fertility problems. The average
self-reported VAS score of their own health was 0.719.
The sample was representative for the Dutch population
(> 18 years) in terms of age and sex. However, a higher
proportion of the respondents were middle and higher
educated than the adult general population. There
self-reported health on the VAS was lower than reported
in another general population time trade-off survey [20].
Respondents above 45 years old had on average 1.6
children, which is similar to the general population in
2017 [6].
Health state valuations
Table 3 shows the utility weights derived with the VAS
and the TTO questions. The TTO utility values of the
infertile health states ranged from 0.792 to 0.868. The
lowest value was given for primary infertility and the
highest for secondary infertility while already having
three children. The confidence intervals were narrow.
The same pattern is visible for the VAS scores, but the
scores are lower than the TTO scores. Likewise, the ad-
justed VAS scores for the subfertile health states were
consistently lower than the TTO scores for the infertile
health states. The lowest score, 0.726, was estimated for
the first subfertile health state: a childless individual dur-
ing a fertility treatment with side effects and uncertainty
about the (final) outcome.
The sample’s valuation of the general health state
(without specific information about having fertility
Fig. 3 Example of Visual analogue scale
Table 2 Sample characteristics
N = 676
Female 0.5133
Age (SD) 45.1 (16.0)
Education, low (elementary school and lowest level of
secondary education)
24%
Education, middle (highest level of secondary education) 40%
Education, high (university degree, bachelor or master) 36%
Respondents with one or more children 59%
Child-wish 33%
Fertility-related problems 12%
Self-reported health, VAS (SD) 0.719
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problems or not) with mild problems on three health
domains (daily activities, pain/discomfort and anxiety/
depression) was very close to the value in the Dutch
tariff (0.784 compared to 0.778).
This general health state was valued higher than
subfertile health states 1 and 2, which were the exact
same health states apart from the additional fertility
information. In other words, the same health state
was valued differently when the cause of the general
health problems was defined, namely IVF treatment
and the related uncertainty of being able to fulfill the
desire to have children. This utility decrement in sub-
fertility with ‘some other health problems’ compared
to the general health state with ‘some other health
problems’, is an indication that the disutility of subfer-
tility cannot be fully captured by the EQ-5D-5 L.
Lastly, primary in−/subfertility was valued lower than
secondary in−/subfertility.
The TTO and adjusted VAS scores for several subsets
of respondents are presented in Table 4. Older respon-
dents valued all health states higher than younger
respondents. A larger difference can be seen between
people with and without the wish to have (more)
children. Respondents who have experienced fertility
problems themselves valued infertile problems higher
(less impact on quality of life) than those who did not
have experience with fertility problems. Conversely,
those respondents with experience with fertility prob-
lems valued subfertile states lower (more impact on
quality of life) than those without experience with fertil-
ity problems. For all other subsets, scores are very close
to those for the full sample.
Reimbursement opinions
In total 29% of the respondents stated that fertility treat-
ments should be fully reimbursed by the health insur-
ance basic benefit package and 8% of respondents stated
fertility treatments should not be reimbursed at all.
Sixty-three percent of all respondents were of opinion
that fertility treatments should be partly reimbursed.
Those respondents thought (on average) that 4.0 IVF
Table 3 VAS and TTO utilities
Health state VAS CI TTO CI
General health state Fertility NS Some other health problems 0.710 0.697 0.723 0.784 0.765 0.803
Infertile 1 Primary infertility No other health problems 0.689 0.674 0.704 0.792 0.771 0.813
Infertile 2 Secondary infertility (1 child) No other health problems 0.751 0.738 0.763 0.845 0.825 0.864
Infertile 3 Secondary infertility (3 children) No other health problems 0.796 0.783 0.808 0.868 0.848 0.887
VAS CI Adjusted VAS CI
Subfertile 1 Primary subfertility Some other health problems 0.640 0.626 0.654 0.726 0.712 0.740
Subfertile 2 Secondary infertility (1 child) Some other health problems 0.662 0.648 0.675 0.747 0.734 0.761
Subfertile 3 Primary subfertility No other health problems 0.675 0.661 0.689 0.761 0.747 0.775
CI confidence interval, TTO time trade-off, VAS visual analogue scale. For more detailed descriptions of health states see Table 1.
Table 4 Comparisons between groups
General health state Infertile 1 Infertile 2 Infertile 3 Subfertile 1 Subfertile 2 Subfertile 3
Women 0.803 0.788 0.843 0.873 0.704 0.825 0.874
Men 0.764 0.796 0.847 0.862 0.798 0.849 0.889
Religious 0.795 0.781 0.842 0.862 0.768 0.837 0.880
Not religious 0.774 0.801 0.847 0.872 0.780 0.836 0.882
Age <45 0.747 0.745 0.797 0.822 0.751 0.814 0.862
Age >=45 0.821 0.841 0.894 0.915 0.799 0.859 0.901
Low education 0.795 0.802 0.823 0.854 0.803 0.837 0.870
Middle 0.786 0.802 0.855 0.885 0.773 0.834 0.879
High 0.774 0.776 0.847 0.857 0.757 0.839 0.891
Experience with fertility problems 0.816 0.811 0.868 0.883 0.737 0.828 0.876
No experience with fertility problems 0.778 0.788 0.842 0.865 0.782 0.840 0.884
Child-wish 0.750 0.708 0.783 0.822 0.741 0.814 0.867
No child-wish 0.806 0.838 0.878 0.892 0.792 0.850 0.889
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attempts (SD 2.5) should be reimbursed by the basic
benefit package.
Discussion
The results of this study indicate that having fertility
problems results in quite substantial disutility according
to the viewpoint of the Dutch general population. Our
estimates of the quality of life of patients with infertility
and subfertility are in the range of those for newly diag-
nosed early ovarian cancer [11], having migraine attacks
twice a week [16] and the quality of life of children with
attention deficit hyperactive disorder with mild to
moderate problems [14]. Primary infertility and primary
subfertility is valued lower (stronger impact on quality of
life) than secondary infertility and subfertility.
Next to the impact of subfertility and infertility on
quality of life, this study also investigated the view of the
Dutch general population on the reimbursement of fer-
tility related treatments. The results show that a strong
majority of the general population is in favour of includ-
ing these treatments in the Dutch mandatory health in-
surance package (basic benefit package). Less than 10%
of the general population sample is of opinion that fertil-
ity treatments should not be covered at all and over a
quarter of the population thinks fertility treatments
should unlimitedly be reimbursed. Individuals who were
of opinion that the reimbursement of fertility treatments
should be limited, indicated that (on average) 4 IVF at-
tempts should be included in the basic benefit package.
Note that currently in the Netherlands 3 IVF attempts
are reimbursed.
Our study has some limitations. First, we used an
online sample. Given that the TTO exercise is relatively
cognitively demanding, this task may have been difficult
for respondents. This idea is strengthened by the sub-
stantial proportion of respondents who answered our
validation questions incorrectly and had to be removed
from the sample. Additionally, our respondents were
higher educated than the Dutch general population.
However, our validation questions did indicate that most
of the respondents understood the task and took it
seriously and provided a similar value for the general
(not infertility-related) health state as the Dutch
EQ-5D-5 L tariff [20]. In general, using online question-
naires has some advantages (such as convenience for re-
spondents, allowing for bigger sample sizes and the
non-existence of interviewer bias) and some disadvan-
tages (for instance, lack of possibility to give additional
instructions when needed and sometimes low response
rates) [9]. A second limitation is that we were not able
to obtain TTO values for the subfertility health states,
because it was not possible to construct a realistic TTO
scenario for these health states. To cope with this, we
adjusted the VAS outcomes of the subfertile health states
to be better comparable with the TTO values of the in-
fertile health states. Thirdly, although we designed the
health state description with a clinical expert, we did not
involve patients in this process. Fourthly, a limitation of
the questionnaire concerning the viewpoint of the Dutch
general population on the reimbursement of fertility
related treatments, is that the questions did not inquire
about the relative importance of reimbursing fertility
treatments. Although the population may be in favour of
reimbursing these treatments, the question remains
whether they should be reimbursed instead of other
treatments. Respondents may be inclined to state that
they find it important to have all possible health care in-
terventions reimbursed. Finally, the results may not be
directly generalizable to other countries.
Some issues related to economic analyses of fertility
treatment remain. For instance, there is a lack of con-
sensus if and how the value of new life should be in-
cluded in these analyses and if effects of treatments on
quality of life should be captured of the couple or of
actively treated individuals only [8]. Therefore, it re-
mains important to further debate on how to capture
and include all relevant costs and effects in economic
analyses of fertility treatments.
To our knowledge, this was the first time that the
impact of primary infertility (involuntary childlessness),
secondary infertility and primary and secondary subferti-
lity is determined in terms of utility outcomes. The
reliability of these estimates was increased by the fact
that our sample closely agreed with the Dutch EQ-5D
tariff on the valuation of a general, non-fertility-related
health state.
This allows for comparing the impact of infertility
and subfertility on quality of life with the impact of
other diseases on quality of life. Moreover, the values
identified in this study can be used in cost-effectiveness
analyses investigating the relative ‘value for money’ of
fertility treatments.
Conclusion
This study identified the utility values of health states in-
volving subfertility or infertility and indicated that sub-
fertility and infertility have a strong negative effect on
quality of life. The identified values allow comparisons
across diseases. This study also showed that there is a
strong support among the Dutch general population for
reimbursing fertility treatments from the Dutch basic
benefit package.
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